TY - JOUR
T1 - Neighborhood Socioeconomic Disadvantage and Care after Myocardial Infarction in the National Cardiovascular Data Registry
AU - Udell, Jacob A.
AU - Desai, Nihar R.
AU - Li, Shuang
AU - Thomas, Laine
AU - de Lemos, James A
AU - Wright-Slaughter, Phyllis
AU - Zhang, Wenying
AU - Roe, Matthew T.
AU - Bhatt, Deepak L.
N1 - Funding Information:
This research was supported by the American College of Cardiology Foundation’s National Cardiovascular Data Registry (NCDR) and a grant from the Heart and Stroke Foundation of Canada (G-15-009034). Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With The Guidelines (ACTION Registry–GWTG) is an initiative of the American College of Cardiology Foundation and the American Heart Association, with partnering support from the Society of Cardiovascular Patient Care, the American College of Emergency Physicians, and the Society of Hospital Medicine. The registry is sponsored in part by the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. Dr Udell is supported in part by a Heart and Stroke National New Investigator/Ontario Clinician Scientist Award, Ontario Ministry of Research and Innovation Early Researcher Award, Women’s College Research Institute and Department of Medicine, Women’s College Hospital; Peter Munk Cardiac Centre, University Health Network; Department of Medicine and Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research, University of Toronto. Role of the sponsor: the study was designed by Drs Udell and Bhatt and approved by the NCDR. The ACTION Registry–GWTG research and publications subcommittee reviewed and approved the proposal and final draft of the article. The funding agency had no role in the conduct of the study; collection, management, analysis, and interpretation of the data; preparation of the article; and decision to submit the article for publication. The views expressed in this article represent those of the authors and do not necessarily represent the official views of the NCDR or its associated professional societies identified at http://www.ncdr.com.
Funding Information:
All authors have completed the ICMJE uniform disclosure form at http://www. icmje.org/coi_disclosure.pdf and declare support from the American College of Cardiology Foundation’s NCDR for the submitted work. We also declare the following financial relationships: Dr Udell: Consulting: Amgen, Boehringer-Ingelheim, Janssen, Merck, Novartis, Sanofi Pasteur; honoraria: Boehringer-In-gelheim, Janssen; grant support: AstraZeneca, Novartis, Sanofi-Aventis. Dr De Lemos: Consulting: Abbott Diagnostics, Amgen, Roche Diagnostics, St. Jude Medical, and Novo Nordisk; grant support from Roche Diagnostics and Abbott Diagnostics. Dr Roe: Research funding: Eli Lilly, Sanofi-Aventis, Amgen, Daiichi-Sanko, Janssen Pharmaceuticals, Ferring Pharmaceuticals, American College of Cardiology, American Heart Association, Familial Hypercholesterolemia Foundation; consulting or honoraria: PriMed, Astra Zeneca, Boehringer-Ingelheim, Merck, Amgen, and Elsevier Publishers. All conflicts of interest are listed at https:// www.dcri.org/about-us/conflict-of-interest. Dr Bhatt discloses the following relationships: Advisory Board: Cardax, Elsevier Practice Update Cardiology, Med-scape Cardiology, Regado Biosciences; Board of Directors: Boston VA Research Institute, Society of Cardiovascular Patient Care; Chair: American Heart Association Quality Oversight Committee; Data Monitoring Committees: Cleveland Clinic, Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine, Population Health Research Institute; Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org; Vice-Chair, ACC Accreditation Committee), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), Harvard Clinical Research Institute (clinical trial steering committee), HMP Communications (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Guest Editor; Associate Editor), Population Health Research Institute (clinical trial steering committee), Slack Publications (Chief Medical Editor, Cardiology Today’s Intervention), Society of Cardiovascular Patient Care (Secretary/Treasurer), WebMD (CME steering committees); Other: Clinical Cardiology (Deputy Editor), NCDR Acute Coronary Treatment and Intervention Outcomes Network Registry Steering Committee (Chair), VA CART Research and Publications Committee (Chair); Research Funding: Abbott, Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Regeneron, Roche, Sanofi-Aventis, The Medicines Company; Royalties: Elsevier (Editor, Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease); Site Co-Investigator: Biotronik, Boston Scientific, St. Jude Medical (now Abbott); Trustee: American College of Cardiology; Unfunded Research: FlowCo, Merck, PLx Pharma, Takeda. All other authors have reported they have no financial relationships to disclose with any organizations that might have an interest in the submitted study in the previous 3 years.
Publisher Copyright:
© 2018 Lippincott Williams and Wilkins. All rights reserved.
PY - 2018/6/1
Y1 - 2018/6/1
N2 - Background: Patients living in disadvantaged neighborhoods are at high risk for adverse outcomes after acute myocardial infarction (MI). Whether residential socioeconomic status (SES) is associated with quality of in-hospital care among patients presenting with MI is unclear. Methods and Results: Multivariable logistic regression was used to examine the relationship between SES, quality of care, and in-hospital cardiovascular outcomes among patients with MI from diverse SES neighborhoods from July 2008 to December 2013, at 586 participating hospitals in the Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines quality improvement program. Patients were categorized according to which SES summary measure group they resided in through linkage with US census block data. Outcomes were in-hospital mortality and major adverse cardiovascular events. Quality of MI care was assessed with the defect-free care measure that delineates the proportion of eligible patients who received all acute and discharge guideline-recommended therapies. Among 390 692 patients, there was a substantially longer median arrival-to-angiography time in lower SES neighborhoods (lowest 8.0 hours, low 5.5 hours, medium 4.8 hours, high 4.5 hours, highest 3.4 hours; P<0.0001), and a higher proportion of ST-segment-elevation myocardial infarction patients treated with fibrinolysis (lowest 23.1%, low 20.2%, medium 18.0%, high 14.2%, highest 5.9%; P<0.0001). However, after adjustment for clinical risk factors, insurance status, and hospital characteristics, socioeconomic disadvantage was not associated with lower rates of guideline-recommended defect-free acute care. Patients presenting from more disadvantaged neighborhoods had a progressively higher independent risk of in-hospital mortality (Pglobal=0.03) and major bleeding (Pglobal<0.001), along with lower quality of discharge care. Conclusions: In this national registry of MI, patients living in the most disadvantaged neighborhoods received equitable in-hospital care compared with advantaged neighborhoods. However, they experienced substantial delays in receiving angiography. Furthermore, patients living in disadvantaged neighborhoods remain at higher risk of adverse in-hospital outcomes after MI, including mortality. These observations suggest there are further opportunities for improvement in acute and discharge MI care.
AB - Background: Patients living in disadvantaged neighborhoods are at high risk for adverse outcomes after acute myocardial infarction (MI). Whether residential socioeconomic status (SES) is associated with quality of in-hospital care among patients presenting with MI is unclear. Methods and Results: Multivariable logistic regression was used to examine the relationship between SES, quality of care, and in-hospital cardiovascular outcomes among patients with MI from diverse SES neighborhoods from July 2008 to December 2013, at 586 participating hospitals in the Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines quality improvement program. Patients were categorized according to which SES summary measure group they resided in through linkage with US census block data. Outcomes were in-hospital mortality and major adverse cardiovascular events. Quality of MI care was assessed with the defect-free care measure that delineates the proportion of eligible patients who received all acute and discharge guideline-recommended therapies. Among 390 692 patients, there was a substantially longer median arrival-to-angiography time in lower SES neighborhoods (lowest 8.0 hours, low 5.5 hours, medium 4.8 hours, high 4.5 hours, highest 3.4 hours; P<0.0001), and a higher proportion of ST-segment-elevation myocardial infarction patients treated with fibrinolysis (lowest 23.1%, low 20.2%, medium 18.0%, high 14.2%, highest 5.9%; P<0.0001). However, after adjustment for clinical risk factors, insurance status, and hospital characteristics, socioeconomic disadvantage was not associated with lower rates of guideline-recommended defect-free acute care. Patients presenting from more disadvantaged neighborhoods had a progressively higher independent risk of in-hospital mortality (Pglobal=0.03) and major bleeding (Pglobal<0.001), along with lower quality of discharge care. Conclusions: In this national registry of MI, patients living in the most disadvantaged neighborhoods received equitable in-hospital care compared with advantaged neighborhoods. However, they experienced substantial delays in receiving angiography. Furthermore, patients living in disadvantaged neighborhoods remain at higher risk of adverse in-hospital outcomes after MI, including mortality. These observations suggest there are further opportunities for improvement in acute and discharge MI care.
KW - angiography
KW - hospital mortality
KW - myocardial infarction
KW - percutaneous coronary intervention
KW - risk factors
KW - social class
UR - http://www.scopus.com/inward/record.url?scp=85053898914&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053898914&partnerID=8YFLogxK
U2 - 10.1161/CIRCOUTCOMES.117.004054
DO - 10.1161/CIRCOUTCOMES.117.004054
M3 - Article
C2 - 29848476
AN - SCOPUS:85053898914
SN - 1941-7713
VL - 11
JO - Circulation: Cardiovascular Quality and Outcomes
JF - Circulation: Cardiovascular Quality and Outcomes
IS - 6
M1 - e004054
ER -